Acute limb ischemia in patient with COVID-19 infection
DOI:
https://doi.org/10.18203/2349-3933.ijam20230374Keywords:
Acute limb ischemia, COVID-19, Hypercoagulability, SARS-CoV-2Abstract
The severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019 caused a worldwide pandemic and became a massive problem in our healthcare system. This infection has broad clinical presentation from asymptomatic to severe symptoms, and unfortunately death. Hypercoagulability associated with this infection can cause a significant morbidity, that increased risk of microthrombosis, vascular hyperpermeability, disseminated intravascular coagulation, and multiorgan failure. Acute limb ischemia (ALI) is the one of coronavirus disease 2019 associated coagulopathy that threaten the limb viability in a very short interval. We report a case of a 98-year-old woman with coronavirus disease 2019 infection, then suddenly has ALI in the right foot.
References
Surya SP, Santoso RM. A clinical case series of COVID-19-associated acute limb ischemia: real-world situation. Egypt Heart J. 2021;73(59):1-7.
Hasan SA, Haque A, Nazir F. Acute Limb Ischemia: A Rare Complication of COVID-19. Cureus. 2020;12(11):1-6.
Singh B, Kaur P, Aldir N, Gupta S, Maroules M. COVID-19 Presenting as Acute Limb Ischemia. Cureus. 2020;12(7):1-4.
Barac S, Onofrei RR, Neagoe PV, Popescu AI. An Observational Study on Patients with Acute Limb Ischemia and SARS-CoV-2 Infection: Early and Late Results in Limb Salvage Rate. J Clin Med. 2021;10(5083):1-10.
Olinic DM, Stanek A, Tataru DA, Homorodean C, Olinic M. Acute Limb Ischemia: An Update on Diagnosis and Management. J Clin Med. 2019;8(1215):1-12.
Topcu AC, Altunyurt GO, Akman D, Batirel A, Demirhan R. Acute Limb Ischemia in Hospitalized COVID-19 Patients. Ann Vasc Surg. 2021;74:88-94.
Ilonzo N, Judelson D, Al-Jundi W, Yana E, et al. A review of acute limb ischemia in COVID-positive patients. Seminars in Vascular Surg. 2021;24:8-12.
Topcu AC, Ariturk C, Yilmaz E. Acute limb ischemia in a COVID-19 patient. Thrombosis Update. 2021;100044:1-4.
Aboyans V, Ricco JB, Bartelink ML, Bjorck M, Brodmann M. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J. 2018;39(9):798-99.
Hage AN, McDevitt JL, Chick JF, Vadlamudi V. Acute Limb Ischemia Therapies: When and How to Treat Endovascularly. Sem Interven Rad. 2018;35:453-60.
Gu SX, Tyagi T, Jain K, Gu VW, Lee SH et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nature Rev Cardiology. 2021;18:194-209.
Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of The Pathophysiological Characteristics and Implications for Antithrombotic Management. J Am Heart Assoc. 2021;10:1-24.
Lorini FL, Matteo MD, Gritti P, Grazioli L. Coagulopathy and COVID-19. Eur Heart J. 2021;23(E):95-8.
Al-zoubi N, Shatnawi N, Jarbo H. Acute Lower Limb Ischemia in Patients Infected with COVID-19. Int J General Surg. 2021;14:833-39.
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40.
Bellosta R, Luzzani L, Natalini G, Pegorer MA. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72(6):1864-72.
McNally MM, Univers J. Acute Limb Ischemia. Surg Clin N Am. 2018;98:1081-96.
